Skip to search formSkip to main contentSkip to account menu

0.9 ML tocilizumab 180 MG/ML Prefilled Syringe [Actemra]

Known as: Actemra 162 MG in 0.9 ML Prefilled Syringe, Actemra 162 MG per 0.9 ML Prefilled Syringe, tocilizumab 180 mg in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Actemra] 
National Institutes of Health

Related topics

Related topics

12 relations

Broader (2)

0.9 ML tocilizumab 180 MG/ML Prefilled Syringetocilizumab Prefilled Syringe [Actemra]
ActemraArginineArginine hydrochlorideHISTIDINE MONOHYDROCHLORIDE MONOHYDRATE

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
ACTEMRA tocilizumab solution injectable par voie sous-cutane
2020
2020
ACTEMRA Tocilizumab Injektionslsung zur subkutanen Anwendung
2015
2015
Recombinant Anti-Idiotypic Antibodies for Antibody Drug Development
LIT.HBPP.V1.2016 © Copyright Bio-Rad Laboratories, Inc. 2016. All rights reserved. Published by Bio-Rad, Endeavour House… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)